FDA Approved: QELBREE — Original Application (Supernus Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved QELBREE (viloxazine hydrochloride) through an original NDA from Supernus Pharmaceuticals, Inc. for the treatment of attention-deficit/hyperactivity…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• QELBREE (viloxazine hydrochloride)

Snippet

ORIG AP for QELBREE (VILOXAZINE HYDROCHLORIDE)